SCHEMBL19829902

SCHEMBL19829902

NC1CCOc2cccc(Cl)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 2/20 0.45
AHR P35869 2/20 0.36
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
ADRA1A P35348 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
CA2 P00918 1/20 0.34
OPRL1 P41146 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
LMNA P02545 2/20 0.32
CRHBP P24387 2/20 0.32
CRHR2 Q13324 2/20 0.32
HTT P42858 1/20 0.32
HTR5A P47898 2/20 0.32
HTR1A P08908 1/20 0.32
HTR1D P28221 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28731754 0.81 CA2 (0.41) AHRSMN1; SMN2CA2TAAR1HTR5A
SCHEMBL136087 0.80 MAP3K14 (0.46) MAP3K14AHRITGB2ICAM1ITGAL
SCHEMBL31300318 0.79 MAP3K14 (0.45) MAP3K14ITGB2ICAM1ITGALADRA2A
SCHEMBL26962672 0.79 MAP3K14 (0.45) MAP3K14ITGB2ICAM1ITGALADRA2A
SCHEMBL27736686 0.79 MAP3K14 (0.67) MAP3K14ITGB2ICAM1ITGALADRA2A
SCHEMBL1266237 0.79 MAP3K14 (0.45) MAP3K14ITGB2ICAM1ITGALADRA2A
SCHEMBL4729948 0.79 MAP3K14 (0.67) MAP3K14ITGB2ICAM1ITGALADRA2A
SCHEMBL30216657 0.79 MAP3K14 (0.45) MAP3K14ITGB2ICAM1ITGALADRA2A
Hydrochloric Acid SCHEMBL4654876 0.77 MAP3K14 (0.65) MAP3K14ITGB2ICAM1ITGALADRA2A
Hydrochloric Acid SCHEMBL26962795 0.77 MAP3K14 (0.44) MAP3K14ITGB2ICAM1ITGALADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180028492-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF PGI DRUG DISCOVERY LLC 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180028492-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF ACHE, CHAT, MAOB MAP3K14 4105/4885AHR 1339/4885ITGB2 3885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.